{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "news_desk": "National", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/12/21/us/21drug/21drug-thumbWide.jpg", "legacy": {"wide": "images/2016/12/21/us/21drug/21drug-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/12/21/us/21drug/21drug-articleLarge.jpg", "legacy": {"xlarge": "images/2016/12/21/us/21drug/21drug-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/12/21/us/21drug/21drug-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/12/21/us/21drug/21drug-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Senate Aims to Stop Price Spikes on Prescription Drugs", "main": "Senate Aims to Stop Firms From \u2018Buying Up Drugs and Jacking Up Prices\u2019"}, "print_page": "13", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Senate", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "United States Politics and Government", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Collins, Susan M", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Turing Pharmaceuticals AG", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Retrophin Inc", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Rodelis Therapeutics", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "10", "name": "organizations"}], "snippet": "A bipartisan report says Congress should prevent huge, unjustified cost increases on decades-old prescription medicines that have no competition....", "source": "The New York Times", "lead_paragraph": "A bipartisan report says Congress should prevent huge, unjustified cost increases on decades-old prescription medicines that have no competition.", "word_count": "964", "pub_date": "2016-12-21T07:00:29+0000", "subsection_name": "Politics", "blog": [], "type_of_material": "News", "section_name": "U.S.", "web_url": "http://www.nytimes.com/2016/12/21/us/politics/prescription-drug-prices.html", "_id": "585a289395d0e039260771b2"}